← Screener

CVSCVS Health

Health care · Pharmacies · NYSE

Compare with peers → Embed

Filings with the SEC since Dec 19, 2017

1,005 filings, 5 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 10, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Nov 4, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Nov 4, 2026

8-K: Regulation FD disclosure

Filed in the last 30 days

of 1,005 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 36 events

Nov 6, 2026Buy Shah Prem S (EVP and Group President) bought $2.0M open-market purchase on Nov 6, 2026
Nov 4, 20268-K Quarterly results 8-K item 2.02
Nov 4, 20268-K Regulation FD disclosure 8-K item 7.01
Nov 4, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Aug 17, 20268-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Aug 5, 20268-K Quarterly results 8-K item 2.02
Aug 5, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
May 22, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · We may offer debt securities from time to time.
May 18, 20268-K Director or officer change, Shareholder vote results 8-K items 5.02, 5.07
May 6, 20268-K Quarterly results 8-K item 2.02
May 6, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Mar 19, 20268-K Director or officer change 8-K item 5.02
Feb 10, 20268-K Quarterly results 8-K item 2.02
Feb 10, 202610-K Annual report (10-K) period ended Dec 31, 2025
Dec 9, 20258-K Regulation FD disclosure 8-K item 7.01
Nov 20, 20258-K Other events 8-K item 8.01
Oct 29, 20258-K Quarterly results 8-K item 2.02
Oct 29, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Sep 22, 20258-K Other events 8-K item 8.01
Aug 15, 20258-K Other events 8-K item 8.01
Jul 31, 20258-K Quarterly results 8-K item 2.02
Jul 31, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
May 20, 20258-K Shareholder vote results 8-K item 5.07
May 1, 20258-K Quarterly results 8-K item 2.02
May 1, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Apr 8, 20258-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Feb 12, 20258-K Quarterly results 8-K item 2.02
Feb 12, 202510-K Annual report (10-K) period ended Dec 31, 2024
Dec 17, 20248-K Other events 8-K item 8.01
Dec 10, 20248-K Other events 8-K item 8.01
Dec 9, 20248-K Other events 8-K item 8.01
Dec 6, 20248-K Other events 8-K item 8.01
Dec 5, 20248-K Other events 8-K item 8.01
Dec 2, 20248-K Other events 8-K item 8.01
Nov 21, 2024SEC letter SEC asked 1 question about Form 10-K letters 2024-11-19 to 2024-11-21
Nov 18, 20248-K Material agreement signed, Director or officer change, Regulation FD disclosure 8-K items 1.01, 5.02, 7.01

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1005 Annual & quarterly 36 Current reports (8-K) 160 Insiders 587 Proxy & votes 31 Big owners (13D/13G) 22 Shares & debt offered 46 SEC letters 21 Other 102

Filed	Form	What it is	Period
Apr 3, 2026	DEFA14A	Extra proxy material		all files
Apr 3, 2026	DEF 14A	Proxy statement	May 14, 2026	all files
Apr 4, 2025	DEFA14A	Extra proxy material		all files
Apr 4, 2025	DEF 14A	Proxy statement	May 15, 2025	all files
Apr 16, 2024	PX14A6G	Shareholder's proxy letter		all files
Apr 5, 2024	DEFA14A	Extra proxy material		all files
Apr 5, 2024	DEF 14A	Proxy statement	May 16, 2024	all files
May 3, 2023	PX14A6G	Shareholder's proxy letter		all files
Apr 26, 2023	PX14A6G	Shareholder's proxy letter		all files
Apr 7, 2023	DEFA14A	Extra proxy material		all files
Apr 7, 2023	DEF 14A	Proxy statement		all files
Sep 7, 2022	DEFA14A	Extra proxy material		all files
Sep 6, 2022	DEFA14A	Extra proxy material		all files
May 11, 2022	PX14A6G	Shareholder's proxy letter		all files
Apr 6, 2022	PX14A6G	Shareholder's proxy letter		all files
Apr 1, 2022	DEFA14A	Extra proxy material		all files
Apr 1, 2022	DEF 14A	Proxy statement	May 11, 2022	all files
Apr 2, 2021	DEFA14A	Extra proxy material		all files
Apr 2, 2021	DEF 14A	Proxy statement	May 13, 2021	all files
May 6, 2020	DEFA14A	Extra proxy material		all files
Apr 24, 2020	DEFA14A	Extra proxy material		all files
Apr 24, 2020	DEFA14A	Extra proxy material		all files
Apr 3, 2020	DEFA14A	Extra proxy material		all files
Apr 3, 2020	DEF 14A	Proxy statement	May 14, 2020	all files
Apr 3, 2020	DEFA14A	Extra proxy material		all files
May 7, 2019	DEFA14A	Extra proxy material		all files
Apr 5, 2019	DEFA14A	Extra proxy material		all files
Apr 5, 2019	DEF 14A	Proxy statement	May 16, 2019	all files
Apr 24, 2018	DEFA14A	Extra proxy material		all files
Apr 24, 2018	DEF 14A	Proxy statement	Jun 4, 2018	all files
Apr 12, 2018	PRE 14A		Jun 4, 2018	all files

Show the other 6 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →